267 related articles for article (PubMed ID: 24008095)
1. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.
Atkinson RL; Yang WT; Rosen DG; Landis MD; Wong H; Lewis MT; Creighton CJ; Sexton KR; Hilsenbeck SG; Sahin AA; Brewster AM; Woodward WA; Chang JC
Breast Cancer Res; 2013; 15(5):R77. PubMed ID: 24008095
[TBL] [Abstract][Full Text] [Related]
2. CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.
Yamamoto H; Masters JR; Dasgupta P; Chandra A; Popert R; Freeman A; Ahmed A
PLoS One; 2012; 7(10):e46979. PubMed ID: 23071686
[TBL] [Abstract][Full Text] [Related]
3. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
4. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
Chen J; Guo T; Zhang L; Qin LX; Singer S; Maki RG; Taguchi T; Dematteo R; Besmer P; Antonescu CR
Genes Chromosomes Cancer; 2012 Feb; 51(2):186-95. PubMed ID: 22076958
[TBL] [Abstract][Full Text] [Related]
5. Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells.
Kai K; Iwamoto T; Kobayashi T; Arima Y; Takamoto Y; Ohnishi N; Bartholomeusz C; Horii R; Akiyama F; Hortobagyi GN; Pusztai L; Saya H; Ueno NT
Oncogene; 2014 Jan; 33(4):440-8. PubMed ID: 23376849
[TBL] [Abstract][Full Text] [Related]
6. Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.
Ying M; Liu G; Shimada H; Ding W; May WA; He Q; Adams GB; Wu L
Oncogene; 2013 Sep; 32(36):4252-63. PubMed ID: 23045288
[TBL] [Abstract][Full Text] [Related]
7. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V
Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
Wei C; Guomin W; Yujun L; Ruizhe Q
Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
[TBL] [Abstract][Full Text] [Related]
11. CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy.
Nadal R; Ortega FG; Salido M; Lorente JA; Rodríguez-Rivera M; Delgado-Rodríguez M; Macià M; Fernández A; Corominas JM; García-Puche JL; Sánchez-Rovira P; Solé F; Serrano MJ
Int J Cancer; 2013 Nov; 133(10):2398-407. PubMed ID: 23661576
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
13. CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.
Meyer MJ; Fleming JM; Lin AF; Hussnain SA; Ginsburg E; Vonderhaar BK
Cancer Res; 2010 Jun; 70(11):4624-33. PubMed ID: 20484027
[TBL] [Abstract][Full Text] [Related]
14. The study of the tumor stem cell properties of CD133+CD44+ cells in the human lung adenocarcinoma cell line A549.
Zhang HZ; Lin XG; Hua P; Wang M; Ao X; Xiong LH; Wu C; Guo JJ
Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1350-8. PubMed ID: 20937222
[TBL] [Abstract][Full Text] [Related]
15. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.
Reddy JP; Atkinson RL; Larson R; Burks JK; Smith D; Debeb BG; Ruffell B; Creighton CJ; Bambhroliya A; Reuben JM; Van Laere SJ; Krishnamurthy S; Symmans WF; Brewster AM; Woodward WA
Breast Cancer Res Treat; 2018 Sep; 171(2):283-293. PubMed ID: 29858753
[TBL] [Abstract][Full Text] [Related]
16. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M
Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
